Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Peter Borek"'
Autor:
Piotr J. Bachul, Karolina Golab, Lindsay Basto, Steven Zangan, Jordan S. Pyda, Angelica Perez-Gutierrez, Peter Borek, Ling-Jia Wang, Martin Tibudan, Dong-Kha Tran, Roi Anteby, Gabriela S. Generette, Jędrzej Chrzanowski, Wojciech Fendler, Laurencia Perea, Kumar Jayant, Aaron Lucander, Celeste Thomas, Louis Philipson, J. Michael Millis, John Fung, Piotr Witkowski
Publikováno v:
Cell Transplantation, Vol 30 (2021)
A recent randomized, multicenter trial did not show benefit of a CXCR1/2 receptor inhibitor (Reparixin) when analysis included marginal islet mass (>3,000 IEQ/kg) for allotransplantation and when immunosuppression regimens were not standardized among
Externí odkaz:
https://doaj.org/article/ea2f1285dd134ef0ab79aab288bd503c
Autor:
Lindsay Basto, Piotr Witkowski, Jordan Pyda, Karolina Golab, Martin Tibudan, Piotr J. Bachul, Peter Borek, Laurencia Perea, Angelica Perez-Gutierrez, Jeffrey B. Matthews, John J. Fung
Publikováno v:
Pancreas
Autor:
Lindsay Basto, Laurencia Perea, John J. Fung, Gabriela S. Generette, Piotr J. Bachul, Jordan Pyda, Martin Tibudan, Aaron Lucander, Roi Anteby, Angelica Perez-Gutierrez, Karolina Golab, Peter Borek, Piotr Witkowski
Publikováno v:
Diabetes. 70
Introduction: Prospective randomized multicenter trial did not find advantage of CXCR1/2 blocker (Reparixin) over placebo in islet transplantation in patients with type 1 diabetes mellitus and problematic hypoglycemia at 1 year follow-up. We note fav
Autor:
Piotr Witkowski, Angelica Perez-Gutierrez, Jayant Kumar, Laurencia Perea, Piotr J. Bachul, Louis H. Philipson, Gabriela S. Generette, Jordan Pyda, Karolina Golab, Peter Borek, Celeste C. Thomas, Lindsay Basto, Braden Juengel, Martin Tibudan, John J. Fung
Publikováno v:
Diabetes. 70
Introduction: Pre-vascularized Sernova Cell Pouch (SCP) device was developed to provide an optimal environment for cell/islet engraftment in the extravascular space. A first-in-human pilot study showed SCP safety/islet vascularization; however, condi
Autor:
Karolina, Golab, Adam, Krzystyniak, Paulina, Langa, Michał, Pikuła, Stefan, Kunovac, Peter, Borek, Piotr, Trzonkowski, J Michael, Millis, John, Fung, Piotr, Witkowski
Publikováno v:
Biomed J Sci Tech Res
SmartFlare™ RNA Detection Probes from Millipore is a novel technology to detect RNA in live cells based on the use of 12 nm gold nanoparticles coated with nucleotides. We proved that SmartFlares™ are internalized by human primary lymphocytes. How
Autor:
Michal Komorniczak, Michael Dimitrov, Martin Tibudan, Aaron Lucander, Piotr Witkowski, Lindsay Basto, John J. Fung, Karolina Golab, Ling-Jia Wang, Sajan Jiv Singh Nagpal, Piotr J. Bachul, Peter Borek, Roi Anteby, Jeffrey B. Matthews, Angelica Perez-Gutierrez, Laurencia Perea
Publikováno v:
Diabetes. 69
Introduction: Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment option for nondiabetic patients with intractable chronic pancreatitis. The outcome and potential benefits for prediabetic and diabetic patients are le
Autor:
Laurencia Perea, Piotr J. Bachul, Braden Juengel, Ling-Jia Wang, Celeste C. Thomas, Martin Tibudan, Gabriela S. Generette, Piotr Witkowski, Louis H. Philipson, Peter Borek, Jayant Kumar, Lindsay Basto, Angelica Perez-Gutierrez, John J. Fung, Karolina Golab
Publikováno v:
Transplantation. 105:S25-S25
Autor:
Roi Anteby, Angelica Perez-Gutierrez, Gabriela S. Generette, Ling-Jia Wang, Rolf N. Barth, John J. Fung, Piotr Witkowski, Martin Tibudan, Lindsay Basto, Piotr J. Bachul, Laurencia Perea, Karolina Golab, Peter Borek
Publikováno v:
Transplantation. 105:S3-S3
Autor:
Celeste C. Thomas, Louis H. Philipson, Dong-Kha V. Tran, Piotr Witkowski, Gabriela S. Generette, Martin Tibudan, J Michael Millis, Aaron Lucander, Peter Borek, Karolina Golab, Jędrzej Chrzanowski, Laurencia Perea, Ling-Jia Wang, Piotr J. Bachul, Roi Anteby, Steven Zangan, Jordan Pyda, Angelica Perez-Gutierrez, Wojciech Fendler, Kumar Jayant, Lindsay Basto, John J. Fung
Publikováno v:
Cell Transplantation, Vol 30 (2021)
Cell Transplantation
Cell Transplantation
A recent randomized, multicenter trial did not show benefit of a CXCR1/2 receptor inhibitor (Reparixin) when analysis included marginal islet mass (>3,000 IEQ/kg) for allotransplantation and when immunosuppression regimens were not standardized among
Autor:
Laurencia Perea, Aaron Lucander, Piotr Witkowski, Martin Tibudan, Lindsay Basto, Roi Anteby, Angelica Perez-Gutierrez, John J. Fung, Piotr J. Bachul, Peter Borek, Ling-Jia Wang, Karolina Golab
Publikováno v:
Transplantation. 104:S566-S566